Sponsored by:

Nuclear Medicine: Page 171

CMS again withholds endorsement of PET beta-amyloid imaging
By Wayne Forrest
For the second time this year, the U.S. Centers for Medicare and Medicaid Services (CMS) has stopped short of fully endorsing PET beta-amyloid imaging for Medicare beneficiaries with dementia or neurodegenerative disease.
July 2, 2013
Molchan takes helm as CEO at Digirad
By AuntMinnie.com staff writers
Digirad President Matthew Molchan has assumed the role of CEO as part of the nuclear medicine firm's restructuring efforts.
July 1, 2013
Univ. of Alberta opens technetium-99m facility
By AuntMinnie.com staff writers
The University of Alberta's new medical isotope and cyclotron facility officially opened on July 2.
July 1, 2013
Covidien's Mallinckrodt spin-off has spun
By AuntMinnie.com staff writers
Mallinckrodt has completed the spin-off from its former parent company Covidien and has launched as a $2.1 billion publicly traded specialty pharmaceutical company.
June 30, 2013
NaF-PET/CT beats scintigraphy, SPECT/CT for bone metastases
By Wayne Forrest
Sodium fluoride (NaF) PET/CT provides greater sensitivity and specificity for the detection of bone metastases than planar bone scintigraphy and SPECT/CT, according to a new pilot study from Copenhagen University Hospital.
June 30, 2013
2013 06 28 15 33 27 935 Petct 200
Navidea begins NAV4694 clinical trial
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has enrolled the first participant in a phase III trial of its NAV4694 PET radiopharmaceutical.
June 26, 2013
PET/CT enhances care for lung cancer patients
By AuntMinnie.com staff writers
PET/CT improves staging accuracy and intrathoracic disease identification, which can lead to improved clinical outcomes for patients with limited-stage small-cell lung cancer, according to a study published in the July issue of the Journal of Thoracic Oncology.
June 26, 2013
Navidea closes $25M debt financing
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has closed a $25 million debt financing transaction led by GE Capital's Healthcare Financial Services division.
June 25, 2013
Nuclear medicine facilities adhering to radiation dose standards
By Wayne Forrest
Nuclear medicine facilities in the U.S. appear to be getting the message about controlling radiation dose. A new survey of more than 300 SPECT and PET centers found that most are keeping dose levels within generally accepted levels.
June 25, 2013
2013 06 10 11 37 50 36 Radiation Symbol 200
CT lung screening is cost-effective; U.S. gamma cameras getting older; PET research falls short
By Brian Casey
June 24, 2013
Survey finds U.S. installed base of gamma cameras is aging
By Wayne Forrest
The average age of gamma cameras at nuclear cardiology labs in the U.S. grew by two years between 2009 and 2011, according to a survey from the University of Missouri. The authors believe that economics is playing a larger role in whether a facility can afford to employ the latest imaging technology.
June 23, 2013
Technologist groups push PET/MRI standards
By AuntMinnie.com staff writers
Two associations representing radiologic technologists have jointly crafted recommendations for PET/MRI education, certification, and staffing requirements for technologists.
June 20, 2013
Previous Page
Page 171 of 440
Next Page